RAPT Therapeutics Inc (RAPT)
1.38
-0.19
(-12.10%)
USD |
NASDAQ |
Nov 14, 11:54
RAPT Therapeutics Shareholders Equity (Quarterly): 109.22M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 109.22M |
| March 31, 2024 | 130.84M |
| December 31, 2023 | 147.04M |
| September 30, 2023 | 172.80M |
| June 30, 2023 | 199.68M |
| March 31, 2023 | 220.47M |
| December 31, 2022 | 245.17M |
| September 30, 2022 | 189.31M |
| June 30, 2022 | 202.13M |
| March 31, 2022 | 167.84M |
| December 31, 2021 | 186.38M |
| September 30, 2021 | 201.87M |
| Date | Value |
|---|---|
| June 30, 2021 | 217.58M |
| March 31, 2021 | 91.64M |
| December 31, 2020 | 104.18M |
| September 30, 2020 | 110.05M |
| June 30, 2020 | 122.61M |
| March 31, 2020 | 131.93M |
| December 31, 2019 | 73.12M |
| September 30, 2019 | -124.80M |
| June 30, 2019 | 60.01M |
| March 31, 2019 | -105.75M |
| December 31, 2018 | -97.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
73.12M
Minimum
Dec 2019
245.17M
Maximum
Dec 2022
159.15M
Average
167.84M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 20.06M |
| FibroGen Inc | -232.34M |
| Cidara Therapeutics Inc | 130.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.18M |
| Total Liabilities (Quarterly) | 17.96M |